Fri, May 31, 2024
In a statement on Thursday, Natco Pharma said: "Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) announces submission of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification with the U.S. Food and Drug Administration (FDA) for the generic version of Rimegepant Sulfate tablet Eq 75mg base strength."
More >
Tue, May 28, 2024
Natco Pharma reported a 40 per cent rise in its profit after tax (PAT) to Rs 386 core in the fourth quarter from Rs 276 crore Year-on-Year (YoY). The pharma company's revenue from operations was up by 19 per cent to Rs 1,068 crore in the quarter under review from Rs 898 crore in the same quarter last fiscal.
Wed, Mar 08, 2023
Natco Pharma shares buyback: Drugmaker through an exchange filing said that it plans to buy back 30 lakh shares which is 1.64 per cent of the paid-up equity shares of the company.
Wed, Oct 04, 2017
With this blockbuster performance, the company's stock has reached nearly two-months high. The last time, Natco's share travelled over Rs 900-mark was on August 08, 2017.
Wed, Jan 25, 2017
Shares of Natco Pharma dropped 0.22% on NSE Nifty after the company said that USFDA conducted an inspection at its pharmaceutical factory in Kothur, near Hyderabad between January 16-24, 2017.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
